Research Paper Volume 14, Issue 4 pp 1959—1982

Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis


Figure 1. The schematic diagram of potential mechanism of different paclitaxel regimens and PRISMA flow diagram. (A) The schematic diagram of the effects of different paclitaxel administration schedules on the survival of cancer cells. (B) Flowchart of the literature search for the 19 eligible RCTs comparing therapeutic efficacy of weekly paclitaxel and 3-weeks paclitaxel administration schedules.